Hayden Hurst
Tight End

Age: 28
Free Agency: 2022 (UFA)
Accrued Seasons: 3
- Height: 6-4
- Weight: 250
- College: South Carolina
- Entry: 2018 Draft, Round 1, #25 overall (Ravens)
- 2021 Salary Cap Charge: $1,984,914 (1.08% of cap)
- 2021 Cash Payout: $1,984,914 (1.50% of spending)
- 2021 Cash to Cap Ratio: 1.00
- Contract Value: $11,036,032 ($2,759,008 APY)
- Fully Guaranteed Money: $10,400,860
- Contract Ranking: 31/155 at TE
Current Contract
(Drafted, signed 2018)
(📝: indicates contract trigger occuring during that year)Year | Age | Base Salary | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
---|---|---|---|---|---|---|---|---|---|---|
2020 | 27 | $1,483,276 | $1,483,276 | $1,483,276 | 0.7% | |||||
2021 | 28 | $1,984,914 | $1,349,742 | $1,984,914 | 1.1% | |||||
Total | $3,468,190 | $2,833,018 | $3,468,190 |
Contract Notes
Hayden Hurst signed a four year contract with the Baltimore Ravens worth $11,036,032 on June 19, 2018. Hurst received $10,400,860 in guarantees including a $6,106,204 signing bonus. The other guaranteed portions of the contract are Hurst's entire 2018, 2019 & 2020 salaries and $1,349,742 of his 2021 salary. Hurst was the 25th pick in the 2018 NFL Draft.
Cash Flows
Old Money | 2020 | 2021 | |
---|---|---|---|
Cash Due | $7,567,842 | $1,483,276 | $1,984,914 |
Running Cash | $9,051,118 | $11,036,032 |
Career Earnings: $9,051,118
Career APY: $3,017,039
Contract History
Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
---|---|---|---|---|---|---|---|---|---|---|
Ravens | Drafted | Traded | 2018 | 4 | $11,036,032 | $2,759,008 | $10,400,860 | $7,567,842 | 68.6% | $3,783,921 |
Falcons | Drafted | Active | 2018 | 4 | $11,036,032 | $2,759,008 | $10,400,860 | $1,483,276 | 13.4% | $1,483,276 |
Earnings By Team
Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
---|---|---|---|---|---|---|---|
Ravens | 2 | $7,567,842 | $3,783,921 | $4,514,740 | 0.0% | $3,053,102 | 0.0% |
Falcons | 1 | $1,483,276 | $1,483,276 | $1,483,276 | 0.0% | $0 | 0.0% |
Season History
Year | Team | Base Salary | Prorated Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
---|---|---|---|---|---|---|---|---|---|
2018 | Ravens | $480,000 | $1,526,551 | $480,000 | $2,006,551 | 1.1% | $6,586,204 | ||
2019 | Ravens | $981,638 | $1,526,551 | $981,638 | $2,508,189 | 1.3% | $981,638 | ||
2020 | Falcons | $1,483,276 | $0 | $1,483,276 | $1,483,276 | 0.7% | $1,483,276 | ||
2021 | Falcons | $1,984,914 | $0 | $1,349,742 | $1,984,914 | 1.1% | $1,984,914 | ||
Total | $4,929,828 | $3,053,102 | $4,294,656 | $7,982,930 | $11,036,032 |
Dead Money History
Team | Year | Cap Charge | Cash Paid |
---|---|---|---|
Ravens | 2020 | $3,053,102 | $0 | Total | $3,053,102 | $0 |
Statistics
Year | Games Played | Games Missed | Snaps | Rushing | Receiving | Fumbles | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Injured | Healthy | Offense | Special | Att | Yards | Avg | TD | Rec | Yards | Avg | TD | Total | Lost | ||
2018 | 12 | 4 | 0 | 23.1% | 7.0% | 1 | 0 | 0.0 | 0 | 13 | 163 | 12.5 | 1 | 0 | 0 |
2019 | 16 | 0 | 0 | 41.4% | 10.3% | 0 | 0 | 0.0 | 0 | 30 | 349 | 11.6 | 2 | 0 | 0 |
2020 | 16 | 0 | 0 | 70.0% | 4.1% | 0 | 0 | 0.0 | 0 | 56 | 571 | 10.2 | 6 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
OTC Valuation | APY | |
---|---|---|
Regular | $7,811,000 | $2,759,008 |
Injury Adjusted | $7,811,000 | $2,759,008 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.